Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. New Zealand
  4. New Zealand Stock Exchange
  5. EBOS Group Limited
  6. News
  7. Summary
    EBO   NZEBOE0001S6

EBOS GROUP LIMITED

(EBO)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

EBOS Group Limited acquired Sentry Medical.

09/01/2021 EDT

EBOS Group Limited (EBOS) acquired Sentry Medical on September 1, 2021. EBOS Group Limited (EBOS) completed the acquisition of Sentry Medical on September 1, 2021.


ę S&P Capital IQ 2021
All news about EBOS GROUP LIMITED
09/22EBOS Group Limited Announces Supplementary Dividend for the Six Months Ended June 30, 2..
CI
09/22EBOS Group Limited Announces Ordinary Dividend for the Six Months Ended June 30, 2021, ..
CI
09/21EBOS : Names Animal Care Division CEO; Shares Up 3%
MT
09/21EBOS Group Limited Appoints Julie Dillon as CEO, Animal Care, Effective 1 November 2021
CI
09/01EBOS : Acquires Sentry Medical
MT
09/01EBOS Group Limited acquired Sentry Medical.
CI
08/18EBOS Group Limited acquired Pioneer Medical Limited for AUD 40 million.
CI
08/17Australia shares rise as upbeat earnings counter BHP slide
RE
08/17EBOS Group Seeks Acquisitions
CI
08/17EBOS : 2021 Full Year Results Investor Presentation
PU
More news
Financials
Sales 2022 10 113 M 7 235 M 7 235 M
Net income 2022 219 M 156 M 156 M
Net Debt 2022 355 M 254 M 254 M
P/E ratio 2022 26,6x
Yield 2022 2,60%
Capitalization 5 820 M 4 170 M 4 164 M
EV / Sales 2022 0,61x
EV / Sales 2023 0,58x
Nbr of Employees 3 105
Free-Float 79,9%
Chart EBOS GROUP LIMITED
Duration : Period :
EBOS Group Limited Technical Analysis Chart | EBO | NZEBOE0001S6 | MarketScreener
Technical analysis trends EBOS GROUP LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 35,85 NZD
Average target price 33,32 NZD
Spread / Average Target -7,07%
EPS Revisions
Managers and Directors
John Cullity Chief Executive Officer
Leonard Hansen Chief Financial Officer
Elizabeth Mary Coutts Chairman
Andrea Bell Chief Information Officer
Sarah Christine Ottrey Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
EBOS GROUP LIMITED24.91%4 217
WALGREENS BOOTS ALLIANCE, INC.21.14%41 818
MCKESSON CORPORATION19.58%32 168
JD HEALTH INTERNATIONAL INC.-50.60%30 366
CARDINAL HEALTH, INC.-9.02%13 819
WELCIA HOLDINGS CO., LTD.9.24%7 761